How many analysts have analysed Genomic Vision (GV.PA)?
The number of analysts covering Genomic Vision (GV.PA) is 8.
Genomic Vision (GV.PA) Forecast, Price Target & Analyst Ratings
EPA:GV • FR0011799907
Current stock price
0.0018 EUR
+0 (+5.88%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Genomic Vision (GV.PA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€0.00
Upside
-100.00%
From current price of €0.00 to mean target of €0.00, Based on 8 analyst forecasts
Low
€0.00
Median
€0.00
High
€0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
35.00%
GV.PA was analyzed by 8 analysts. The buy percentage consensus is at 35. So analysts seem to be rather negative about GV.PA.
In the previous month the buy percentage consensus was at a similar level.
GV.PA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 1.084M -38.76% | 994K -8.30% | 1.026M 3.22% | |
| EBITDA YoY % growth | -4.788M -4.75% | -4.664M 2.59% | -5.436M -16.55% | |
| EBIT YoY % growth | -5.377M -15.66% | -4.895M 8.96% | -6.122M -25.07% | |
| Operating Margin | -496.03% | -492.45% | -596.69% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A